ロード中...
Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer
OBJECTIVES: Effective management of adverse events (AEs) following vandetanib treatment is important to maximize clinical benefits. We examined whether more frequent contact with vandetanib-treated patients reduced AEs of CTCAE grade 2 or higher. STUDY DESIGN: In this open-label, multicentre, phase...
保存先:
| 出版年: | Eur Thyroid J |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5091223/ https://ncbi.nlm.nih.gov/pubmed/27843809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448919 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|